Management of low-risk prostate cancer.

Management of low-risk prostate cancer.

Détails bibliographiques
Auteurs principaux:	Gardiner, R, Hamdy, F
Format:	Journal article
Langue:	English
Publié:	2008

Documents similaires

THE ROLE OF ACTIVE MONITORING IN THE MANAGEMENT OF PROSTATE CANCER
par: Hamdy, F
Publié: (2009)

Early diagnosis and surgical management of prostate cancer.
par: Linton, K, et autres
Publié: (2003)

[Early diagnosis and surgical management of prostate cancer]
par: Linton, D, et autres
Publié: (2004)

Early diagnosis and surgical management of prostate cancer
par: Linton, D, et autres
Publié: (2004)

Staging in prostate cancer.
par: Wilkinson, B, et autres
Publié: (2002)

Screening for prostate cancer: an update.
par: Bryant, R, et autres
Publié: (2008)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
par: Hamdy, F
Publié: (2005)

Prostate cancer: screening approaches.
par: Donovan, J, et autres
Publié: (2005)

Prostate cancer: screening approaches
par: Donovan, J, et autres
Publié: (2005)

Long-term quality of life in prostate cancer.
par: Hamdy, F
Publié: (2011)

Long-term quality of life in prostate cancer
par: Hamdy, F
Publié: (2011)

The prostate cancer prevention trial and its messages.
par: Hamdy, F
Publié: (2007)

Novel biomarkers for the detection of prostate cancer
par: Jakobsen, N, et autres
Publié: (2017)

Three dimensional ultrasound and prostate cancer.
par: Mehta, S, et autres
Publié: (2004)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
par: Vickers, A, et autres
Publié: (2010)

Endothelin and skeletal metastases in hormone-refractory prostate cancer
par: Hamdy, F
Publié: (2003)

Screening for prostate cancer. The case against.
par: Donovan, J, et autres
Publié: (2005)

Screening for prostate cancer remains controversial.
par: Neal, D, et autres
Publié: (2009)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
par: Macefield, R, et autres
Publié: (2009)

Screening for prostate cancer: views from the UK and the rest of the world
par: Hamdy, F
Publié: (2003)

10-year outcomes in localized prostate cancer.
par: Hamdy, F, et autres
Publié: (2017)

Curative radiation therapy in prostate cancer.
par: Harmenberg, U, et autres
Publié: (2011)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
par: Lamb, A, et autres
Publié: (2018)

Identification of new genetic risk factors for prostate cancer.
par: Guy, M, et autres
Publié: (2009)

Metabolic imbalance and prostate cancer progression.
par: Burton, A, et autres
Publié: (2010)

Familial risk of prostate cancer in Iceland.
par: Eldon, B, et autres
Publié: (2003)

Vasectomy and the Risk of Prostate Cancer COMMENTS
par: Goldacre, M
Publié: (2008)

Imaging proteolysis in prostate cancer and stromal cells
par: Molokwu, C, et autres
Publié: (2007)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
par: Shui, I, et autres
Publié: (2014)

The spectrum of prostate cancer care: From curative intent to palliation
par: Ali, A, et autres
Publié: (2008)

Time for a “radical” change to active surveillance for prostate cancer?
par: Donovan, J, et autres
Publié: (2018)

The spectrum of prostate cancer care: from curative intent to palliation.
par: Ali, A, et autres
Publié: (2007)

Orient expression: solving the mystery of Asian prostate cancer?
par: Lamb, A, et autres
Publié: (2017)

Diagnostic pathways for screen-detected prostate cancer: The plot thickens
par: Hamdy, F, et autres
Publié: (2017)

The Prostate Testing for Cancer and Treatment (ProtecT) study: what have we learnt?
par: Hamdy, F
Publié: (2017)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
par: Shui, I, et autres
Publié: (2014)

The role of osteoprotegerin in breast and prostate cancer
par: Holen, I, et autres
Publié: (2002)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
par: Hamdy, F, et autres
Publié: (2006)

Markers of bone turnover and disease status in prostate cancer
par: Hannon, R, et autres
Publié: (2003)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
par: Hamdy, F, et autres
Publié: (2006)